Grand Medical Group

About us

Grand Medical Group AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

read more

10 Kornmarkt Street, CH - 6004 Luzern, Switzerland

info@grandmedicalgroup.ch

+41 415880810

1 film-coated tablet contains: 250 mg azithromycin, No6
1 film-coated tablet contains: 500 mg azithromycin, No3
Each vial contains 500 mg of azithromycin as powder for solution for infusion, vial No1

PHARMACOLOGIC PROPERTIES

ATC code: J01FA10, Antibacterials for systemic use, macrolides, azithromycin
Azithromycin is a macrolide antibiotic belonging to the azalide group. The mechanism of action of azithromycin is based on the suppression of bacterial protein synthesis, that is to say that it binds to the ribosomal 50s sub-unit and inhibits the translocation of peptides. Azithromycin acts bacteriostatic.

THERAPEUTIC INDICATIONS

Azithromycin is indicated for the treatment of the following infections, when caused by microorganisms sensitive to azithromycin:
• Acute bacterial sinusitis (adequately diagnosed)
• Acute bacterial otitis media (adequately diagnosed)
• Pharyngitis/tonsillitis
• Acute exacerbation of chronic bronchitis (adequately diagnosed)
• Mild to moderately severe community-acquired pneumonia
• Skin and soft tissue infections
• Uncomplicated Chlamydia trachomatis urethritis and cervicitis.

Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms, in adult patients where initial intravenous therapy is required.
Azithromycin as powder for solution for infusion is indicated for the treatment of pelvic in?ammatory disease (PID) due to susceptible microorganisms, in patients where initial intravenous therapy is required.

LEAFLETS